A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

NCT02436460 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Re-initiate a new trial per the discussion with FDA

Conditions

Acute Graft Versus Host Disease

Interventions

BIOLOGICAL: AbGn-168H

Sponsor

AbGenomics B.V Taiwan Branch